Sana Biotechnology Inc [NASDAQ: SANA] gained 24.40% or 0.41 points to close at $2.09 with a heavy trading volume of 10229763 shares.
The daily chart for SANA points out that the company has recorded -19.31% loss over the past six months.
If we look at the average trading volume of 3.42M shares, SANA reached to a volume of 10229763 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Sana Biotechnology Inc [SANA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SANA shares is $8.80 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SANA stock is a recommendation set at 1.29. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citizens JMP have made an estimate for Sana Biotechnology Inc shares, keeping their opinion on the stock as Mkt Outperform, with their previous recommendation back on March 18, 2025. While these analysts kept the previous recommendation, Jefferies raised their target price to Buy. The new note on the price target was released on March 14, 2025, representing the official price target for Sana Biotechnology Inc stock.
The Average True Range (ATR) for Sana Biotechnology Inc is set at 0.21 The Price to Book ratio for the last quarter was 2.25, with the Price to Cash per share for the same quarter was set at 0.48.
Trading performance analysis for SANA stock
Sana Biotechnology Inc [SANA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.43. With this latest performance, SANA shares gained by 31.45% in over the last four-week period, additionally sinking by -19.31% over the last 6 months – not to mention a drop of -75.56% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SANA stock in for the last two-week period is set at 59.47, with the RSI for the last a single of trading hit 65.39, and the three-weeks RSI is set at 54.93 for Sana Biotechnology Inc [SANA]. The present Moving Average for the last 50 days of trading for this stock 1.8900, while it was recorded at 1.8000 for the last single week of trading, and 3.1000 for the last 200 days.
Sana Biotechnology Inc [SANA]: A deeper dive into fundamental analysis
Sana Biotechnology Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.40 and a Current Ratio set at 3.40.
Sana Biotechnology Inc [SANA]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SANA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sana Biotechnology Inc go to 13.94%.
An analysis of Institutional ownership at Sana Biotechnology Inc [SANA]
The top three institutional holders of SANA stocks are: FMR LLC with ownership of 27.17 million shares, which is approximately 11.5894%. FLAGSHIP PIONEERING INC., holding 25.0 million shares of the stock with an approximate value of $$136.51 million in SANA stocks shares; and FLAGSHIP PIONEERING INC., currently with $$70.32 million in SANA stock with ownership which is approximately 5.4934%.
